Life | Free Full-Text | Considering Predictive Factors in the Diagnosis of Clinically Significant Prostate Cancer in Patients with PI-RADS 3 Lesions
JPM | Free Full-Text | Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies
Cancer detection by PI-RADS score and overall | Download Scientific Diagram
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy | Journal of Urology
The Radiology Assistant : Prostate Cancer - PI-RADS v2
Frontiers | Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions
Analysis of PI-RADS 4 cases_ Management recommendations for negatively biopsied patients
pn_391_1.PNG
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? | Semantic Scholar
Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org
Gallium 68 PSMA-11 PET/CT Imaging in Patients with PI-RADS 3 | Journal of Nuclear Medicine
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology
A Comparison of Image-Guided Targeted Prostate Biopsy Outcomes by PI-RADS® Score and Ethnicity in a Diverse, Multiethnic Population | Journal of Urology
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect
Prostate cancer in PI-RADS scores 1 and 2 version 2.1: a comparison to previous PI-RADS versions | SpringerLink
Frontiers | Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies
The Radiology Assistant : Prostate Cancer - PI-RADS v2
PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract
Early experience in avoiding biopsies for biopsy-naïve men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL2: A 2-year follow-up study -
The basics of PI-RADS scoring and how AI can help
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology
An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study - The
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect
Results from a PI-RADS-based MRI-directed diagnostic pathway for biopsy-naive patients in a non-university hospital | SpringerLink
